| William Wayne Hooper, MD | |
|
320 Santa Fe Dr, Suite 101, Encinitas, CA 92024-5138 | |
| (760) 753-3424 | |
| (760) 753-3425 |
| Full Name | William Wayne Hooper |
|---|---|
| Gender | Male |
| Speciality | Pulmonary Disease |
| Experience | 49 Years |
| Location | 320 Santa Fe Dr, Encinitas, California |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1720052988 | NPI | - | NPPES |
| 290014892 | Other | RAILROAD MEDICARE | |
| 350050500 | Other | US DEPT OF LABOR |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RP1001X | Internal Medicine - Pulmonary Disease | G35446 (California) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Scripps Memorial Hospital - Encinitas | Encinitas, CA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Scott A Eisman Md Inc | 6901052513 | 12 |
News Archive
Researchers at National Jewish Health have discovered how a lipid secreted by cancer tumors prevents the immune system from mounting an immune response against it. When lysophosphatidic acid binds to killer T cells, it acts almost like an "invisibility cloak," preventing T cells from recognizing and attacking nascent tumors.
Debiopharm Group, a global biopharmaceutical development specialist that focuses on serious medical conditions and particularly oncology, and Ascepion Pharmaceuticals, Inc., a privately-held, biopharmaceutical company dedicated to the discovery and development of breakthrough small molecule drugs for the treatment of oncology and related diseases, have entered into an exclusive worldwide license agreement concerning the development and commercialization of ASP-08126 (called Debio 1144 by Debiopharm) a multikinase inhibitor currently in pre-clinical development.
A review of studies looking into the health effects of estrogen-containing cows' milk has found that the milk is likely to be safe for human consumption.
No one knows how many mothers' and babies' lives have been saved by the obstetrical forceps. This device has been part of the standard equipment of every maternity room for about 250 years. However, a shadow lies over the success story: after the Chamberlen brothers developed the device at the beginning of the 17th century, the brothers and their descendants used it for 3 generations, but kept it a secret from other obstetricians.
A team of researchers led by Professor Richard Hayes at the London School of Hygiene and Tropical Medicine has been awarded $37 million to test an innovative combination of strategies to prevent HIV in African countries.
› Verified 8 days ago
| Entity Name | Acute Care Associates Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1841387214 PECOS PAC ID: 8628027547 Enrollment ID: O20050118001038 |
News Archive
Researchers at National Jewish Health have discovered how a lipid secreted by cancer tumors prevents the immune system from mounting an immune response against it. When lysophosphatidic acid binds to killer T cells, it acts almost like an "invisibility cloak," preventing T cells from recognizing and attacking nascent tumors.
Debiopharm Group, a global biopharmaceutical development specialist that focuses on serious medical conditions and particularly oncology, and Ascepion Pharmaceuticals, Inc., a privately-held, biopharmaceutical company dedicated to the discovery and development of breakthrough small molecule drugs for the treatment of oncology and related diseases, have entered into an exclusive worldwide license agreement concerning the development and commercialization of ASP-08126 (called Debio 1144 by Debiopharm) a multikinase inhibitor currently in pre-clinical development.
A review of studies looking into the health effects of estrogen-containing cows' milk has found that the milk is likely to be safe for human consumption.
No one knows how many mothers' and babies' lives have been saved by the obstetrical forceps. This device has been part of the standard equipment of every maternity room for about 250 years. However, a shadow lies over the success story: after the Chamberlen brothers developed the device at the beginning of the 17th century, the brothers and their descendants used it for 3 generations, but kept it a secret from other obstetricians.
A team of researchers led by Professor Richard Hayes at the London School of Hygiene and Tropical Medicine has been awarded $37 million to test an innovative combination of strategies to prevent HIV in African countries.
› Verified 8 days ago
| Entity Name | Scott A Eisman Md Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1801184031 PECOS PAC ID: 6901052513 Enrollment ID: O20120815000319 |
News Archive
Researchers at National Jewish Health have discovered how a lipid secreted by cancer tumors prevents the immune system from mounting an immune response against it. When lysophosphatidic acid binds to killer T cells, it acts almost like an "invisibility cloak," preventing T cells from recognizing and attacking nascent tumors.
Debiopharm Group, a global biopharmaceutical development specialist that focuses on serious medical conditions and particularly oncology, and Ascepion Pharmaceuticals, Inc., a privately-held, biopharmaceutical company dedicated to the discovery and development of breakthrough small molecule drugs for the treatment of oncology and related diseases, have entered into an exclusive worldwide license agreement concerning the development and commercialization of ASP-08126 (called Debio 1144 by Debiopharm) a multikinase inhibitor currently in pre-clinical development.
A review of studies looking into the health effects of estrogen-containing cows' milk has found that the milk is likely to be safe for human consumption.
No one knows how many mothers' and babies' lives have been saved by the obstetrical forceps. This device has been part of the standard equipment of every maternity room for about 250 years. However, a shadow lies over the success story: after the Chamberlen brothers developed the device at the beginning of the 17th century, the brothers and their descendants used it for 3 generations, but kept it a secret from other obstetricians.
A team of researchers led by Professor Richard Hayes at the London School of Hygiene and Tropical Medicine has been awarded $37 million to test an innovative combination of strategies to prevent HIV in African countries.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| William Wayne Hooper, MD 320 Santa Fe Dr, Suite 101, Encinitas, CA 92024-5138 Ph: (760) 753-3424 | William Wayne Hooper, MD 320 Santa Fe Dr, Suite 101, Encinitas, CA 92024-5138 Ph: (760) 753-3424 |
News Archive
Researchers at National Jewish Health have discovered how a lipid secreted by cancer tumors prevents the immune system from mounting an immune response against it. When lysophosphatidic acid binds to killer T cells, it acts almost like an "invisibility cloak," preventing T cells from recognizing and attacking nascent tumors.
Debiopharm Group, a global biopharmaceutical development specialist that focuses on serious medical conditions and particularly oncology, and Ascepion Pharmaceuticals, Inc., a privately-held, biopharmaceutical company dedicated to the discovery and development of breakthrough small molecule drugs for the treatment of oncology and related diseases, have entered into an exclusive worldwide license agreement concerning the development and commercialization of ASP-08126 (called Debio 1144 by Debiopharm) a multikinase inhibitor currently in pre-clinical development.
A review of studies looking into the health effects of estrogen-containing cows' milk has found that the milk is likely to be safe for human consumption.
No one knows how many mothers' and babies' lives have been saved by the obstetrical forceps. This device has been part of the standard equipment of every maternity room for about 250 years. However, a shadow lies over the success story: after the Chamberlen brothers developed the device at the beginning of the 17th century, the brothers and their descendants used it for 3 generations, but kept it a secret from other obstetricians.
A team of researchers led by Professor Richard Hayes at the London School of Hygiene and Tropical Medicine has been awarded $37 million to test an innovative combination of strategies to prevent HIV in African countries.
› Verified 8 days ago
Alberto Bessudo, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 326 Santa Fe Dr Ste 105, Encinitas, CA 92024 Phone: 760-452-3340 Fax: 760-452-3344 | |
Dr. Gordon L. Kim, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 326 Santa Fe Dr, Encinitas, CA 92024 Phone: 760-753-5594 | |
Dr. Wesley Shih, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 354 Santa Fe Dr, Encinitas, CA 92024 Phone: 760-230-2251 Fax: 760-230-2253 | |
Batyrjan Bulibek, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 320 Santa Fe Dr Ste 204, Encinitas, CA 92024 Phone: 760-944-7300 Fax: 760-633-3949 | |
Dr. Gay Mcmanus Walker, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 477 N El Camino Real, Suite 208a, Encinitas, CA 92024 Phone: 760-479-3900 Fax: 760-479-3923 | |
Dr. Richard Michael Jacoby, MD Pulmonary Disease Medicare: May Accept Medicare Assignments Practice Location: 700 Garden View Ct Ste 204, Encinitas, CA 92024 Phone: 760-452-6334 Fax: 760-349-9755 | |
Dr. Anjali Anil Bharne, M.D Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1200 Garden View Rd, Suite 200, Encinitas, CA 92024 Phone: 760-536-7700 Fax: 760-536-7710 |